Positive pre-clinical data published using ReNeuron’s CTX cells in artificial nerve tissue generated as part of a grant-funded collaboration

26 January 2018: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce the publication of new positive data in a pre-clinical model of nerve injury which demonstrated comparable nerve regeneration compared to standard of care treatment and a stronger muscle function response.

Read more …